zoledronic acid has been researched along with Hypertension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beck, JT; Bilic, S; Isaacs, R; Iyer, SP; Kelly, KR; Munshi, NC; Sen, S; Shah, J; Stewart, AK | 1 |
| Andrada, E; Cánovas, V; Carrato, A; Guillén-Ponce, C; Guirado-Risueño, M; Martín Hidalgo, A; Molina, MA; Molina, MJ; Molina-Garrido, MJ; Mora, A; Pastor, E | 1 |
1 trial(s) available for zoledronic acid and Hypertension
| Article | Year |
|---|---|
A Phase IB multicentre dose-determination study of BHQ880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related events.
Topics: Aged; Anabolic Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Resorption; Diphosphonates; Drug Therapy, Combination; Female; Fractures, Spontaneous; Humans; Hypertension; Imidazoles; Intercellular Signaling Peptides and Proteins; Male; Maximum Tolerated Dose; Middle Aged; Molecular Targeted Therapy; Multiple Myeloma; Neoplasm Proteins; Osteolysis; Recurrence; Spinal Cord Compression; Zoledronic Acid | 2014 |
1 other study(ies) available for zoledronic acid and Hypertension
| Article | Year |
|---|---|
Multiple bone lesions resembling a metastatic origin. An unexpected diagnosis.
Topics: Aged; Anemia; Back Pain; Bone Density Conservation Agents; Bone Neoplasms; Diagnosis, Differential; Diphosphonates; Female; Humans; Hypertension; Imidazoles; Immunologic Factors; Interferon-alpha; Magnetic Resonance Imaging; Mastocytosis, Systemic; Osteolysis; Osteoporosis; Radionuclide Imaging; Zoledronic Acid | 2008 |